GF
HBIO icon

Gabelli Funds’s Harvard Bioscience HBIO Stock Holding History

Gabelli Funds’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,900
Closed -$26.1K – 1295
2025
Q4 		$26.1K Hold
3,900
– – ﹤0.01% 1223
2025
Q3 		$17.1K Sell
3,900
-1,100
-22% -$5.22K ﹤0.01% 1225
2025
Q2 		$22.2K Sell
5,000
-1,500
-23% -$6.27K ﹤0.01% 1196
2025
Q1 		$36.8K Hold
6,500
– – ﹤0.01% 1059
2024
Q4 		$137K Buy
6,500
+500
+8% +$11.5K ﹤0.01% 1034
2024
Q3 		$161K Buy
6,000
+1,500
+33% +$44.2K ﹤0.01% 1024
2024
Q2 		$128K Buy
+4,500
New +$158K ﹤0.01% 1019

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return